PerkinElmer, Inc. And Jacobi Medical Center Establish Research Collaboration To Develop Molecular Diagnostics Screening Platforms

PerkinElmer, Inc. (NYSE: PKI), a global leader in Health Sciences and Photonics, today announced a research collaboration agreement with Jacobi Medical Center, which is currently developing a centralized molecular genetics diagnostic laboratory that will ultimately serve the Health and Hospitals Corporation (HHC) of New York City. The collaboration will focus on the development of a genetic screening platform for neonatal, pre-natal and maternal/adult healthcare.

Back to news